pillbase.ru

Relistor

Active substance: methylnaltrexone

methylnaltrexone bromide

Centralised EU authorisationActive

Marketing holder: Bausch Health Ireland Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • Relistor
    INJECTION, SOLUTION · METHYLNALTREXONE BROMIDE 8 mg/.4mL
    65649-552
    Salix Pharmaceuticals, Inc.
  • Relistor
    INJECTION, SOLUTION · METHYLNALTREXONE BROMIDE 12 mg/.6mL
    65649-551
    Salix Pharmaceuticals, Inc.
  • Relistor
    TABLET · METHYLNALTREXONE BROMIDE 150 mg/1
    65649-150
    Salix Pharmaceuticals, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-afb4-7bec-b424-584a73690f2c,01a12090-89c5-703c-b67a-3f278af2d0aa,01a12096-e8af-7cf3-b829-3e36fac5c6e6;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/000870
Registration status
Active
ATC code
A06AH01
Sources
  • product · EMA · EMEA/H/C/000870 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/000870 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/000870 · Verified 2026-10-09